<DOC>
	<DOCNO>NCT01352936</DOCNO>
	<brief_summary>Staphylococcus aureus , virulent many staphylococcal specie , recognize one important lethal human bacterial pathogen . With increased incidence methicillin-resistant staphylococcus aureus ( MRSA ) infection community hospitalize patient , MRSA infection associate great lengths stay , high mortality , increased cost . Vancomycin teicoplanin , two commonly use glycopeptides first-choice treatment MRSA infection . Vancomycin-induced nephrotoxicity still point controversy . Teicoplanin known nephrotoxicity . Acute kidney injury common complication critical illness , report 5 7 % hospitalized patient . It associate significantly increase mortality , length stay , cost across broad spectrum condition .</brief_summary>
	<brief_title>Comparison Nephrotoxicity Hospital Costs Patients With Methicillin-Resistant Staphylococcus Aureus Bacteremia Who Received Vancomycin Versus Teicoplanin Therapy</brief_title>
	<detailed_description>In retrospective observational study , data collection perform use patient list extract medical management system Taipei Medical University-Wan Fang Hospital . Hospitalized patient prescribe either vancomycin teicoplanin treat bloodstream infection cause MRSA least one serum creatinine data within 7 day initiate glycopeptide therapy recruit study . The major outcome variable interest new onset nephrotoxicity , define decrease glomerular filtration rate ( GFR ) 25 % 50 % baseline base serial serum creatinine ( SCr ) measurement . Other variable include age admission , gender , comorbidities , laboratory data , concurrent medication ( e.g. , drug name , dose , route , dose interval , start date end date ) , medical cost information also obtain database . We perform observational clinical study 2 main goal : ( 1 ) determine rate nephrotoxicity mortality patient MRSA bacteremia treat vancomycin teicoplanin ; ( 2 ) determine whether vancomycin-associated nephrotoxicity increase length stay cost .</detailed_description>
	<mesh_term>Bacteremia</mesh_term>
	<mesh_term>Staphylococcal Infections</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<mesh_term>Methicillin</mesh_term>
	<mesh_term>Teicoplanin</mesh_term>
	<criteria>Hospitalized patient prescribe either vancomycin teicoplanin treat bloodstream infection cause MRSA least one serum creatinine data within 7 day initiate glycopeptide therapy recruit study . Patients age less 15 year admission exclude . Those switch treatment vancomycin teicoplanin vise versa hospitalization also exclude avoid possible carryover effect . Because main objective study compare magnitude consequence nephrotoxicity associate two study medication , patient underwent dialysis glycopeptides treatment exclude .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>nephrotoxicity</keyword>
	<keyword>hospital cost</keyword>
	<keyword>Staphylococcus aureus</keyword>
	<keyword>bacteremia</keyword>
	<keyword>vancomycin</keyword>
	<keyword>teicoplanin</keyword>
</DOC>